Skip to main content
OpenTrials

Clinical trial condition

Locally Advanced Pancreatic Cancer

Explore clinical trials studying Locally Advanced Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

29 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Locally Advanced Pancreatic Cancer trial results

Recruiting

Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC

NCT03257033

Conditions
Locally Advanced Pancreatic Cancer
Locations
  • VA Loma Linda Healthcare System Loma Linda, California, United States
  • Sutter Cancer Center Sacramento Sacramento, California, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Comprehensive Cancer Care and Research Institute of Colorado, CCCRIC Englewood, Colorado, United States
View all 42 locations
View Trial Details
Recruiting

A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer

NCT06944587

Conditions
Borderline Resectable Pancreatic Cancer, Chemotherapy Effect, Locally Advanced Pancreatic Cancer, +1 more
Locations
  • Haukeland University Hospital Bergen, Norway
  • Stavanger University Hospital Stavanger, Norway
  • University Hospital of North Norway Tromsø, Norway
  • St. Olavs Hospital, Trondheim University Hospital Trondheim, Norway
View Trial Details
Recruiting

Clinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer

NCT05653453

Conditions
Locally Advanced Pancreatic Cancer
Locations
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
  • Cancer Hospital of Shandong First Medical University Jinan, Shandong, China
  • Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
  • Fudan University Affiliated Huashan Hospital Shanghai, Shanghai Municipality, China
View Trial Details
Recruiting

mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer

NCT06761027

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations
  • First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China
  • Fujian Provincial Hospital Fuzhou, Fujian, China
  • Mengchao Hepatobiliary Hospital of Fujian Medical University Fuzhou, Fujian, China
  • Zhangzhou Affiliated Hospital of Fujian Medical University Zhangzhou, Fujian, China
View Trial Details
Not Yet Recruiting

Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer

NCT07325214

Conditions
Borderline Resectable Pancreatic Cancer, Digestive System Diseases, Digestive System Neoplasms, +8 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • University of Texas Health Science Center at San Antonio San Antonio, Texas, United States
  • University of Virginia Medical Center Charlottesville, Virginia, United States
  • Seoul National University Bundang Hospital, Gyeonggi-do, South Korea
View Trial Details

Related conditions